✦ LIBER ✦

Norepinephrine: the next therapeutics frontier for Parkinson's disease

✍ Scribed by Peter A LeWitt

Book ID: 115028121
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 125 KB
Volume: 1
Category: Article
ISSN: 2047-9158
DOI: 10.1186/2047-9158-1-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting phosphatases as the next gener

Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson’s disease

✍ Steven P. Braithwaite; Michael Voronkov; Jeffry B. Stock; M. Maral Mouradian 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Astrocytes and therapeutics for Parkinso

Astrocytes and therapeutics for Parkinson’s disease

✍ Phillip M. Rappold; Kim Tieu 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 439 KB

Levodopa therapeutics for Parkinson's di

Levodopa therapeutics for Parkinson's disease: new developments

✍ Peter A. LeWitt 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Therapeutic directions for Parkinson's d

Therapeutic directions for Parkinson's disease

✍ Ira Shoulson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

## Abstract The focus on disease‐modifying treatments and cures for Parkinson's disease (PD) has raised expectations for quantum leaps and overshadowed incremental gains that have been slowly achieved. Large multi‐center clinical trials such as DATATOP and PRECEPT keep on generating new knowledge t

Therapeutic angiogenesis: the next front

Therapeutic angiogenesis: the next frontier for interventional radiology

✍ Robert P Liddell; Clifford R Weiss; Lawrence V Hofmann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 513 KB

Pharmacological Synergy: The Next Fronti

Pharmacological Synergy: The Next Frontier on Therapeutic Advancement for Migraine

✍ Andrew Blumenfeld; Chris Gennings; Roger Cady 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB